» Articles » PMID: 37998052

Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer's Disease

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2023 Nov 24
PMID 37998052
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's Disease (AD) is a progressive neurodegenerative disorder impairing cognition and memory in the elderly. This disorder has a complex etiology, including senile plaque and neurofibrillary tangle formation, neuroinflammation, oxidative stress, and damaged neuroplasticity. Current treatment options are limited, so alternative treatments such as herbal medicine could suppress symptoms while slowing cognitive decline. We followed PRISMA guidelines to identify potential herbal treatments, their associated medicinal phytochemicals, and the potential mechanisms of these treatments. Common herbs, including , , , , and , produced promising pre-clinical results. These herbs are rich in kaempferol and quercetin, flavonoids with a polyphenolic structure that facilitate multiple mechanisms of action. These mechanisms include the inhibition of Aβ plaque formation, a reduction in tau hyperphosphorylation, the suppression of oxidative stress, and the modulation of BDNF and PI3K/AKT pathways. Using pre-clinical findings from quercetin research and the comparatively limited data on kaempferol, we proposed that kaempferol ameliorates the neuroinflammatory state, maintains proper cellular function, and restores pro-neuroplastic signaling. In this review, we discuss the anti-AD mechanisms of quercetin and kaempferol and their limitations, and we suggest a potential alternative treatment for AD. Our findings lead us to conclude that a polyherbal kaempferol- and quercetin-rich cocktail could treat AD-related brain damage.

Citing Articles

The Role of Genetic, Environmental, and Dietary Factors in Alzheimer's Disease: A Narrative Review.

Mertas B, Bosgelmez I Int J Mol Sci. 2025; 26(3).

PMID: 39940989 PMC: 11818526. DOI: 10.3390/ijms26031222.


Ellagic acid alleviates NLRP6/caspase-1/GSDMD-mediated inflammation and pyroptosis in rats post cerebral ischemia/reperfusion injury.

Ling Hu , Wei X, Shen G, Huang X Iran J Basic Med Sci. 2025; 28(1):105-112.

PMID: 39877634 PMC: 11771333. DOI: 10.22038/ijbms.2024.78864.17057.


De novo biosynthesis of quercetin in Yarrowia Lipolytica through systematic metabolic engineering for enhanced yield.

Dong Y, Wei W, Li M, Qian T, Xu J, Chu X Bioresour Bioprocess. 2025; 12(1):5.

PMID: 39841399 PMC: 11754545. DOI: 10.1186/s40643-024-00825-w.


Molecular Signaling Pathways of Quercetin in Alzheimer's Disease: A Promising Arena.

Alsaleem M, Al-Kuraishy H, Al-Gareeb A, Albuhadily A, Alrouji M, Yassen A Cell Mol Neurobiol. 2024; 45(1):8.

PMID: 39719518 PMC: 11668837. DOI: 10.1007/s10571-024-01526-w.


Alzheimer's Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models).

Toledano A, Rodriguez-Casado A, Alvarez M, Toledano-Diaz A Brain Sci. 2024; 14(11).

PMID: 39595866 PMC: 11591712. DOI: 10.3390/brainsci14111101.


References
1.
Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M . Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res. 1998; 31(4):317-23. DOI: 10.1016/s0168-0102(98)00061-3. View

2.
Ajiboye B, Ojo O, Okesola M, Akinyemi A, Talabi J, Idowu O . In vitro antioxidant activities and inhibitory effects of phenolic extract of (Oliv and Hiern) against key enzymes linked with type II diabetes mellitus and Alzheimer's disease. Food Sci Nutr. 2018; 6(7):1803-1810. PMC: 6189626. DOI: 10.1002/fsn3.749. View

3.
Cheng B, Martinez A, Morado J, Scofield V, Roberts J, Maffi S . Retinoic acid protects against proteasome inhibition associated cell death in SH-SY5Y cells via the AKT pathway. Neurochem Int. 2012; 62(1):31-42. DOI: 10.1016/j.neuint.2012.10.014. View

4.
Latta C, Brothers H, Wilcock D . Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy. Neuroscience. 2014; 302:103-11. PMC: 4602369. DOI: 10.1016/j.neuroscience.2014.09.061. View

5.
Rasouli H, Hosseini Ghazvini S, Yarani R, Altintas A, Jooneghani S, Ramalho T . Deciphering inhibitory activity of flavonoids against tau protein kinases: a coupled molecular docking and quantum chemical study. J Biomol Struct Dyn. 2020; 40(1):411-424. DOI: 10.1080/07391102.2020.1814868. View